Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Clinuvel Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: PainChek reveals exactly how much its grown in 2019; and says there’s more to come next year
Health & Biotech
The health sector has been the ASX’s top performer in 2019, but could a recession stop it in its tracks?
Health & Biotech
Here’s what policymakers must do keep ASX life science companies from going overseas
Health & Biotech
Dr Boreham’s Crucible: Can Phylogica finally make magic happen after nearly 15 years of trying?
Health & Biotech
Biotech investors get ready to catch the next wave
Health & Biotech
Dr Boreham’s Crucible: the story of Clinuvel, an Australian triumph
Health & Biotech
The life sciences investment wave is building. Here’s how to ride it.
Health & Biotech
Clinuvel on top of the world after FDA approval caps off rise of 4000%
Health & Biotech
Clinuvel surges to all-time high on US green light
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
Health & Biotech
Clinuvel shares seesaw as D-Day approaches
Health & Biotech
FDA reviews Aussie drug that helps people who are allergic to sunlight
Health & Biotech
